As of June 8, 2025, Sunshine Biopharma Inc (SBFM) reports a Forward P/E of 1.98.
Forward P/E gauges the price investors pay for each dollar of anticipated earnings, offering insight into a stock's future valuation.
Comparing Sunshine Biopharma Inc's Forward P/E to Peers
To better understand Sunshine Biopharma Inc's position, it's useful to compare its Forward P/E against industry peers. Below are selected comparisons:
| Company | Forward P/E |
|---|---|
| Sunshine Biopharma Inc (SBFM) | 1.98 |
| Ocuphire Pharma Inc (OCUP) | 9.27 |
| Phio Pharmaceuticals Corp (PHIO) | 0.67 |
Compared to its competitors, Sunshine Biopharma Inc's Forward P/E is about average compared to peers, indicating growth expectations in line with industry peers.